Minerva Neurosciences | NERV - Equity Capital And Reserves

Minerva Neurosciences reported $-20024000 in Equity Capital and Reserves for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 400.41M 25.27M
Adma Biologics ADMA:US USD 151.97M 51.59M
ALKERMES ALKS:US USD 1.04B 899K
AstraZeneca AZN:LN USD 37.04B 1.9B
Biocryst Pharmaceuticals BCRX:US USD -294597000 51.94M
Dynavax Technologies DVAX:US USD 581.01M 80.44M
Esperion Therapeutics ESPR:US USD -323778000 29.68M
GlaxoSmithKline GSK:LN GBP 10.6B 1.45B
Halozyme Therapeutics HALO:US USD 169.8M 72.81M
IONIS PHARMACEUT IONS:US USD 572.89M 21.47M
Marinus Pharmaceuticals MRNS:US USD 116M 34M
Minerva Neurosciences NERV:US USD -20024000 5.78M
Neurocrine Biosciences NBIX:US USD 1.71B 163.2M
Novartis NOVN:VX USD 59.34B 1.48B
Novavax NVAX:US USD -634078000 68.09M
Roche Holding ROG:VX 27.99B 2.8B
Takeda 4502:JP JPY 6.18T 536.95B
Vanda Pharmaceuticals VNDA:US USD 527.2M 11.54M